Euromedis Laboratories - 2025 Half-Year Financial Results

Laboratoires Euromedis' revenue reached €20.4 million in the first half of 2025, marking an 11% increase compared to the previous year. This rise was driven by increased activity in public procurement, private distribution, and export sales. Gross margin increased by 8% to €5.7 million, representing 27.9% of revenue.

The gross operating surplus returned to positive territory with +€0.1 million compared to a loss of €0.4 million a year earlier, and the net result was positive at +€0.1 million, a marked improvement compared to the loss of €0.5 million on June 30, 2024. However, logistics infrastructure was affected by social movements, increasing costs.

For the second half of 2025, the company anticipates a continuation of these positive trends, while remaining attentive to economic and logistical uncertainties. Cost and supply chain optimization measures remain a priority.